Cargando…

Circ-SFMBT2 drives the malignant phenotypes of esophageal cancer by the miR-107-dependent regulation of SLC1A5

BACKGROUND: Increasing studies focused on the regulatory roles of circular RNAs (circRNAs) in diverse cancers. This study was to evaluate the function and mechanism of circRNA Scm-like with four malignant brain tumor domains 2 (circ-SFMBT2) in esophageal cancer (EC). METHODS: The circ-SFMBT2, microR...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Zhiwei, Fu, Yang, Jia, Yongxu, Gao, Ming, Song, Lijie, Zhang, Weijie, Zhao, Ruihua, Qin, Yanru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447765/
https://www.ncbi.nlm.nih.gov/pubmed/34530825
http://dx.doi.org/10.1186/s12935-021-02156-8
_version_ 1784569086720606208
author Chang, Zhiwei
Fu, Yang
Jia, Yongxu
Gao, Ming
Song, Lijie
Zhang, Weijie
Zhao, Ruihua
Qin, Yanru
author_facet Chang, Zhiwei
Fu, Yang
Jia, Yongxu
Gao, Ming
Song, Lijie
Zhang, Weijie
Zhao, Ruihua
Qin, Yanru
author_sort Chang, Zhiwei
collection PubMed
description BACKGROUND: Increasing studies focused on the regulatory roles of circular RNAs (circRNAs) in diverse cancers. This study was to evaluate the function and mechanism of circRNA Scm-like with four malignant brain tumor domains 2 (circ-SFMBT2) in esophageal cancer (EC). METHODS: The circ-SFMBT2, microRNA-107 (miR-107) and solute-linked carrier family A1 member 5 (SLC1A5) levels were analyzed by quantitative real-time polymerase chain reaction (qRT-PCR). Cell proliferation was evaluated by 3-(4, 5-dimethylthiazol-2-y1)-2, 5-diphenyl tetrazolium bromide (MTT) assay, colony formation assay and EdU assay. Cell apoptosis and invasion were detected by flow cytometry and transwell assay. Glutamine metabolism was assessed by the corresponding kits for glutamine consumption, α-ketoglutarate production and glutamate production. Western blot was used for protein quantification. The binding analysis was performed using dual-luciferase reporter assay, RNA immunoprecipitation (RIP) and pull-down assays. The functional research of circ-SFMBT2 in vivo was performed by xenograft tumor assay. Exosomes were identified by morphological observation and protein detection. RESULTS: Circ-SFMBT2 was overexpressed in EC samples and cells. Circ-SFMBT2 downregulation inhibited EC cell proliferation, invasion and glutamine metabolism. Circ-SFMBT2 targeted miR-107 and the regulation of circ-SFMBT2 was achieved by sponging miR-107. SLC1A5 was a target of miR-107, and it worked as an oncogene in EC cells. MiR-107 retarded the EC progression by downregulating SLC1A5. Circ-SFMBT2 could affect the SLC1A5 expression by targeting miR-107. Circ-SFMBT2 regulated EC progression in vivo by miR-107/SLC1A5 axis. Circ-SFMBT2 was transferred by exosomes in EC cells. CONCLUSION: These results suggested that circ-SFMBT2 upregulated the SLC1A5 expression to promote the malignant development of EC by serving as a miR-107 sponge. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-021-02156-8.
format Online
Article
Text
id pubmed-8447765
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-84477652021-09-20 Circ-SFMBT2 drives the malignant phenotypes of esophageal cancer by the miR-107-dependent regulation of SLC1A5 Chang, Zhiwei Fu, Yang Jia, Yongxu Gao, Ming Song, Lijie Zhang, Weijie Zhao, Ruihua Qin, Yanru Cancer Cell Int Primary Research BACKGROUND: Increasing studies focused on the regulatory roles of circular RNAs (circRNAs) in diverse cancers. This study was to evaluate the function and mechanism of circRNA Scm-like with four malignant brain tumor domains 2 (circ-SFMBT2) in esophageal cancer (EC). METHODS: The circ-SFMBT2, microRNA-107 (miR-107) and solute-linked carrier family A1 member 5 (SLC1A5) levels were analyzed by quantitative real-time polymerase chain reaction (qRT-PCR). Cell proliferation was evaluated by 3-(4, 5-dimethylthiazol-2-y1)-2, 5-diphenyl tetrazolium bromide (MTT) assay, colony formation assay and EdU assay. Cell apoptosis and invasion were detected by flow cytometry and transwell assay. Glutamine metabolism was assessed by the corresponding kits for glutamine consumption, α-ketoglutarate production and glutamate production. Western blot was used for protein quantification. The binding analysis was performed using dual-luciferase reporter assay, RNA immunoprecipitation (RIP) and pull-down assays. The functional research of circ-SFMBT2 in vivo was performed by xenograft tumor assay. Exosomes were identified by morphological observation and protein detection. RESULTS: Circ-SFMBT2 was overexpressed in EC samples and cells. Circ-SFMBT2 downregulation inhibited EC cell proliferation, invasion and glutamine metabolism. Circ-SFMBT2 targeted miR-107 and the regulation of circ-SFMBT2 was achieved by sponging miR-107. SLC1A5 was a target of miR-107, and it worked as an oncogene in EC cells. MiR-107 retarded the EC progression by downregulating SLC1A5. Circ-SFMBT2 could affect the SLC1A5 expression by targeting miR-107. Circ-SFMBT2 regulated EC progression in vivo by miR-107/SLC1A5 axis. Circ-SFMBT2 was transferred by exosomes in EC cells. CONCLUSION: These results suggested that circ-SFMBT2 upregulated the SLC1A5 expression to promote the malignant development of EC by serving as a miR-107 sponge. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-021-02156-8. BioMed Central 2021-09-16 /pmc/articles/PMC8447765/ /pubmed/34530825 http://dx.doi.org/10.1186/s12935-021-02156-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Primary Research
Chang, Zhiwei
Fu, Yang
Jia, Yongxu
Gao, Ming
Song, Lijie
Zhang, Weijie
Zhao, Ruihua
Qin, Yanru
Circ-SFMBT2 drives the malignant phenotypes of esophageal cancer by the miR-107-dependent regulation of SLC1A5
title Circ-SFMBT2 drives the malignant phenotypes of esophageal cancer by the miR-107-dependent regulation of SLC1A5
title_full Circ-SFMBT2 drives the malignant phenotypes of esophageal cancer by the miR-107-dependent regulation of SLC1A5
title_fullStr Circ-SFMBT2 drives the malignant phenotypes of esophageal cancer by the miR-107-dependent regulation of SLC1A5
title_full_unstemmed Circ-SFMBT2 drives the malignant phenotypes of esophageal cancer by the miR-107-dependent regulation of SLC1A5
title_short Circ-SFMBT2 drives the malignant phenotypes of esophageal cancer by the miR-107-dependent regulation of SLC1A5
title_sort circ-sfmbt2 drives the malignant phenotypes of esophageal cancer by the mir-107-dependent regulation of slc1a5
topic Primary Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447765/
https://www.ncbi.nlm.nih.gov/pubmed/34530825
http://dx.doi.org/10.1186/s12935-021-02156-8
work_keys_str_mv AT changzhiwei circsfmbt2drivesthemalignantphenotypesofesophagealcancerbythemir107dependentregulationofslc1a5
AT fuyang circsfmbt2drivesthemalignantphenotypesofesophagealcancerbythemir107dependentregulationofslc1a5
AT jiayongxu circsfmbt2drivesthemalignantphenotypesofesophagealcancerbythemir107dependentregulationofslc1a5
AT gaoming circsfmbt2drivesthemalignantphenotypesofesophagealcancerbythemir107dependentregulationofslc1a5
AT songlijie circsfmbt2drivesthemalignantphenotypesofesophagealcancerbythemir107dependentregulationofslc1a5
AT zhangweijie circsfmbt2drivesthemalignantphenotypesofesophagealcancerbythemir107dependentregulationofslc1a5
AT zhaoruihua circsfmbt2drivesthemalignantphenotypesofesophagealcancerbythemir107dependentregulationofslc1a5
AT qinyanru circsfmbt2drivesthemalignantphenotypesofesophagealcancerbythemir107dependentregulationofslc1a5